Fitch Puts Pfizer on Watch Negative, Notes Leverage Increase

Date : 06/19/2019 @ 7:38PM
Source : Dow Jones News
Stock : Pfizer, Inc. (PFE)
Quote : 42.51  -0.24 (-0.56%) @ 4:11PM

Fitch Puts Pfizer on Watch Negative, Notes Leverage Increase

Pfizer (NYSE:PFE)
Historical Stock Chart

1 Month : From Jun 2019 to Jul 2019

Click Here for more Pfizer Charts.

By Michael Dabaie


Fitch Ratings said it placed Pfizer Inc. (PFE) ratings on Rating Watch Negative.

Pfizer's proposed deal for Array BioPharma Inc. (ARRY) makes strategic sense, according to Fitch, increasing its presence in oncology. Pfizer this week agreed to buy Array for $10.64 billion in cash.

Fitch said it expects the acquisition will increase leverage, which is already currently stressed for Pfizer's current "A+" rating.

"The company continues to demonstrate little appetite for reducing leverage, despite the more tax-efficient access to its international cash generation provided by 2017 tax reform," Fitch said.

The ratings agency said it will resolve the Negaive Watch when the deal closes and it anticipates a one-notch downgrade of the Long-Term Issuer Default Rating to "A" is likely.


Write to Michael Dabaie at


(END) Dow Jones Newswires

June 19, 2019 14:23 ET (18:23 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest PFE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.